Zobrazeno 1 - 10
of 18
pro vyhledávání: '"C. A. Floudas"'
Publikováno v:
The Thoracic and Cardiovascular Surgeon. 57:187-190
Sarcoidosis is a systemic disease which affects many organs, including the heart. Cardiac sarcoidosis has a reported incidence of about 25 % and carries a poor prognosis. It can occur in the form of conduction abnormalities, pericardial and valvular
Autor:
K. M. Westerberg, C. A. Floudas
Publikováno v:
The Journal of Chemical Physics. 110:9259-9295
We propose a new method for calculating all stationary states, including saddle points of all orders, of a potential energy surface based on the αBB deterministic branch and bound global optimization algorithm. This method is based on rigorous optim
Autor:
I, Moyssakis, E, Gialafos, N, Tentolouris, C S, Floudas, T G, Papaioannou, Ch, Kostopoulos, P, Latsi, G, Vaiopoulos, V, Votteas, A, Rapti
Publikováno v:
European journal of clinical investigation. 38(2)
Systemic sarcoidosis (Sar) is a granulomatous disorder involving multiple organs. Widespread vascular involvement and microangiopathy are common in patients with Sar. In addition, subclinical cardiac involvement is increasingly recognized in patients
Autor:
H. Rabitz, C. A. Floudas
This research dealt with (i) the molecular structure prediction via global optimization methods, (ii) the sensitivity analysis, and (iii) molecular dynamics simulations. Rigorous global optimization methods were proposed and applied to oligopeptides,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7df70e6adc0271e93c0d702abea46e89
https://doi.org/10.21236/ada380561
https://doi.org/10.21236/ada380561
Publikováno v:
Proteins. 29(1)
Human leukocyte antigens (HLA) or histocompatibility molecules are glycoproteins that play a pivotal role in the development of an effective immune response. An important function of the HLA molecules is the ability to bind and present antigen peptid
Autor:
Helen Gogas, Y. Metaxas, G. Fountzilas, Urania Dafni, Francesco M. Marincola, Ena Wang, Maria Spyropoulou-Vlachou, C. S. Floudas, Lorenzo Uccellini, Alessandro Monaco
Publikováno v:
ResearcherID
8538 Background: Attempts to identify patients who benefit from adjuvant treatment with interferon alfa-2b (IFN) have been disappointing. The development of autoimmunity during adjuvant therapy with IFN cannot assist selection of patients for therapy
Autor:
Helen Gogas, Dimosthenis Tsoutsos, M. Spyropoulou-Vlachou, G. Fountzilas, Antonios Antoniadis, M. Mantzourani, Y. Metaxas, D.G. Pectasides, C. S. Floudas, Aristidis Polyzos
Publikováno v:
Journal of Clinical Oncology. 27:9049-9049
9049 Background: Attempts to identify patients who benefit from adjuvant treatment of interferon alfa-2b (IFN) have been disappointing. Interleukin-10 polymorphisms have been implicated with the prognosis of patients with advanced melanoma and associ
Autor:
C. A. Floudas
Publikováno v:
Journal of Global Optimization. 32:159-159
Publikováno v:
Journal of Combinatorial Optimization; Aug2005, Vol. 10 Issue 1, p41-60, 20p